Literature DB >> 599408

The clinical pharmacokinetics of phenytoin.

E Martin, T N Tozer, L B Sheiner, S Riegelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 599408     DOI： 10.1007/bf01059685

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  33 in total

1.  Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations.

Authors:  L B Sheiner; H Halkin; C Peck; B Rosenberg; K L Melmon
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

2.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

3.  Dicoumarol-induced diphenylhydantoin intoxication.

Authors:  J M Hansen; M Kristensen; L Skovsted; L K Christensen
Journal:  Lancet       Date:  1966-07-30       Impact factor: 79.321

4.  Pharmacokinetic study of a patient with diphenylhydantoin toxicity.

Authors:  A J Atkinson; J M Shaw
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin.

Authors:  D W Shoeman; D L Azarnoff
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

6.  Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationships in children.

Authors:  L G Borofsky; S Louis; H Kutt; M Roginsky
Journal:  J Pediatr       Date:  1972-11       Impact factor: 4.406

7.  Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients.

Authors:  G W Houghton; A Richens; P A Toseland; S Davidson
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

8.  Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients.

Authors:  G W Houghton; A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-04       Impact factor: 4.335

9.  [Plasma concentration of phenytoin in epileptics--importance for the clinician].

Authors:  T Deonna; G de Crousaz; G Magrini; P Bechtel; J L Schelling
Journal:  Schweiz Med Wochenschr       Date:  1975-07-26

10.  Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers.

Authors:  N Gerber; R Lynn; J Oates
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391
View more
  37 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

3.  Piperine in food: interference in the pharmacokinetics of phenytoin.

Authors:  T Velpandian; R Jasuja; R K Bhardwaj; J Jaiswal; S K Gupta
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Oct-Dec       Impact factor: 2.441

4.  Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

Authors:  G Lam; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

5.  Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model.

Authors:  Rob Ter Heine; Sean P Kane; Alwin D R Huitema; Matthew D Krasowski; Erik M van Maarseveen
Journal:  Br J Clin Pharmacol       Date:  2019-08-07       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

Review 7.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 8.  Drug disposition in obese humans. An update.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

9.  Steady-state pharmacokinetics of phenytoin from routinely collected patient data.

Authors:  T H Grasela; L B Sheiner; B Rambeck; H E Boenigk; A Dunlop; P W Mullen; J Wadsworth; A Richens; T Ishizaki; K Chiba
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

10.  Phenytoin elimination kinetics in two children with drug intoxication.

Authors:  K Abe; M Okano; H Sasaki
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.